Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-02-07
2006-02-07
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S509000
Reexamination Certificate
active
06995155
ABSTRACT:
Compounds of formula (I) are disclosed. The compounds inhibit the action of gamma secretase, and hence find use in the treatment and prevention of Alzheimer's disease.
REFERENCES:
patent: 2004/0082572 (2004-04-01), Pineiro et al.
patent: WO 95 14471 (1995-06-01), None
patent: WO 98 28268 (1998-07-01), None
patent: WO 00 14073 (2000-03-01), None
patent: WO 00 38618 (2000-07-01), None
Churcher Ian
Nadin Alan John
Owens Andrew Pate
Merck Sharp & Dohme Limited
Todaro John C.
Winokur Melvin
LandOfFree
Benzodiazepine derivatives as inhibitors of gamma secretase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzodiazepine derivatives as inhibitors of gamma secretase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzodiazepine derivatives as inhibitors of gamma secretase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3674869